Does BENDROFLUMETHIAZIDE Cause Mobility decreased? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Mobility decreased have been filed in association with BENDROFLUMETHIAZIDE. This represents 0.6% of all adverse event reports for BENDROFLUMETHIAZIDE.
6
Reports of Mobility decreased with BENDROFLUMETHIAZIDE
0.6%
of all BENDROFLUMETHIAZIDE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Mobility decreased From BENDROFLUMETHIAZIDE?
Of the 6 reports, 6 (100.0%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENDROFLUMETHIAZIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BENDROFLUMETHIAZIDE Cause?
Hyponatraemia (332)
Acute kidney injury (192)
Confusional state (127)
Hypotension (101)
Vomiting (71)
Dizziness (64)
Hypokalaemia (64)
Fall (60)
Malaise (58)
Agitation (57)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which BENDROFLUMETHIAZIDE Alternatives Have Lower Mobility decreased Risk?
BENDROFLUMETHIAZIDE vs BENIDIPINE
BENDROFLUMETHIAZIDE vs BENLYSTA
BENDROFLUMETHIAZIDE vs BENRALIZUMAB
BENDROFLUMETHIAZIDE vs BENSERAZIDE
BENDROFLUMETHIAZIDE vs BENSERAZIDE\LEVODOPA